NATCO launches Chlorantraniliprole (CTPR) formulated product NATGEN

NATCO launches Chlorantraniliprole (CTPR) formulated product NATGEN

By: IPP Bureau

Last updated : September 26, 2022 9:40 am



NATCO estimates the current market size of CTPR containing products in India to be over Rs. 2,000 crore.


Natco Pharma Limited has launched Chlorantraniliprole (CTPR) 18.5% SC under the Brand Name of NATGEN in the Indian Market.

NATCO estimates the current market size of CTPR containing products in India to be over Rs. 2,000 crore.

NATCO NATGEN

First Published : September 26, 2022 12:00 am